Stanford to test antiviral pills as long COVID treatment
By
Alicia Lasek
Nov 28, 2022
Investigators plan to test whether the antiviral drug Paxlovid will relieve symptoms of the syndrome known as long COVID, also called post-acute sequelae of COVID-19.
New COVID booster shot rollout expected near Labor Day: officials
By
Alicia Lasek
Aug 25, 2022
The FDA expects to soon authorize omicron-targeting shots. The White House is planning to distribute them as part of a fall vaccination campaign, federal officials say.
FDA greenlights first home COVID test with traditional premarket review
By
Alicia Lasek
Jun 07, 2023
The Cue COVID-19 Molecular Test is the first at-home COVID-19 test to be granted marketing authorization outside of emergency use authorities, representing a new era of consumer access to diagnostic tests,...
New data show high excess mortality from RSV, reduced threat from flu among older adults
By
Alicia Lasek
Mar 02, 2022
The first such study in 13 years finds nuanced changes in the risk that flu and respiratory syncytial virus pose to seniors, and underscores the impact of the 2009 H1N1 flu pandemic on infections and deaths...
COVID shot boosters for all adults will help to reduce confusion, FDA says
By
Alicia Lasek
Nov 22, 2021
The FDA “heard loud and clear” that a simpler booster strategy was needed, its vaccine chief says. But the action may be too late to head off a winter virus surge, observers say.
Fed’s booster OK too late? Nursing home loses 8 to coronavirus outbreak this fall
By
Alicia Lasek
Nov 17, 2021
A Connecticut nursing home has weathered a facility-wide COVID-19 outbreak that has sickened 89 residents and staff. Booster shots were not yet authorized when the first cases appeared, the operator reports.
Healthcare workers account for at least 20% of COVID-19 cases
By
Alicia Lasek
Apr 15, 2020
The number comes from state reports and is likely an underestimation, according to the CDC.
FDA approves pill to treat deadly C. difficile infections
By
Alicia Lasek
Apr 28, 2023
The first-of-its-kind fecal microbiota pill treats recurrent infections caused by Clostridium difficile, an antibiotic-resistant bacterium that’s a danger to nursing home residents.
Best bet against omicron? Prior infection or a booster shot, early research suggests
By
Alicia Lasek
Dec 09, 2021
A two-dose course of the Pfizer-BioNTech COVID-19 vaccine may not be enough to effectively combat the new omicron coronavirus variant, but a booster shot may do the trick, two early lab studies suggest....
One person with COVID infects 4 to 5 others, double WHO estimates, study finds
By
Alicia Lasek
Oct 01, 2020
Each person who contracted the coronavirus early in the pandemic likely transmitted it to four or five others, according to a new analysis.